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Abstract: The global population of multimorbid older people is growing steadily. 
Multimorbidity is the principal cause of complex polypharmacy, which in turn is the prime risk 
factor for inappropriate prescribing and adverse drug reactions and events. Those who prescribe 
for older frailer multimorbid people are particularly prone to committing prescribing errors of 
various kinds. The causes of prescribing errors in this patient population are multifaceted and 
complex, including prescribers’ lack of knowledge of aging physiology, geriatric medicine, 
and geriatric pharmacotherapy, overprescribing that frequently leads to major polypharmacy, 
inappropriate prescribing, and inappropriate drug omission. This review examines the various 
ways of minimizing prescribing errors in multimorbid older people. The role of education in 
physician prescribers and clinical pharmacists, the use of implicit and explicit prescribing 
criteria designed to improve medication appropriateness in older people, and the application 
of information and communication-technology systems to minimize errors are discussed in 
detail. Although evidence to support any single intervention to prevent prescribing errors in 
multimorbid elderly people is inconclusive or lacking, published data support focused prescriber 
education in geriatric pharmacotherapy, routine application of STOPP/START (screening tool 
of older people’s prescriptions/screening tool to alert to right treatment) criteria for potentially 
inappropriate prescribing, electronic prescribing, and close liaison between clinical pharmacists 
and physicians in relation to structured medication review and reconciliation. Carrying out a 
structured medication review aimed at optimizing pharmacotherapy in this vulnerable patient 
population presents a major challenge. Another challenge is to design, build, validate, and test 
by clinical trials suitably versatile and efficient software engines that can reliably and swiftly 
perform complex medication reviews in older multimorbid people. The European Union-funded 
SENATOR and OPERAM clinical trials commencing in 2016 will examine the impact of 
customized software engines in reducing medication-related morbidity, avoidable excess cost, 
and rehospitalization in older multimorbid people.
Keywords: prescribing errors, multimorbidity, aged
Introduction
According to the UN, an “older person” is 60 years or older, with persons aged $80 years 
being referred to as the “oldest old”.1 The global population is aging, with the number of 
people aged over 65 years expected to reach 71 million by 2030, compared to 35 million 
in 2000. By 2050, the global average life expectancy is predicted to have increased by 
10 years compared to 2000,2 and by 2080, the over-80 population will likely double.
With the predicted global demographic shift, the prevalence of multimorbidity, 
defined as two or more concurrent chronic medical conditions, will rise. At present, 
81.5% of people aged over 85 years experience multimorbidity, compared to 62% of 
those aged 65–74 years and 50% of those under 65 years.3 Multimorbidity is three 
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times more prevalent in those aged 85 years compared to 
those aged 70 years.4 Multimorbid patients are prescribed 
more medications, which increases their risk of inappropriate 
prescribing (IP),5 drug–drug interactions,6 drug–disease 
interactions, adverse drug events (ADEs),7 and medication 
errors,8 all of which are intimately linked. Problems associated 
with all aspects of prescribing will increase amid an aging 
multimorbid population unless they are clearly identified and 
comprehensively addressed. This review examines prescrib-
ing errors in the multimorbid older population, and proposes 
potentially feasible strategies to address them.
Definition
In the literature, “medication error” and “prescribing error” 
are often used interchangeably, making study comparisons 
difficult. Distinguishing medication errors from prescribing 
errors is important, as different types of errors are influenced 
by different factors, result in different outcomes, and require 
different actions. Ferner and Aronson defined a medication 
error as “a failure in the treatment process that leads to, or 
has the potential to lead to, harm to the patient”.9 However, 
this definition of medication error encompasses prescribing 
errors, administration errors, and dispensing errors.
In 2000, through a Delphi consensus panel of doctors, 
surgeons, pharmacists, nurses, and risk managers, Dean et al 
proposed that significant prescription errors happen when 
without intention, the probability of timely and effective 
treatment is reduced and/or the risk of drug-related adversity 
is heightened.10
Prescribing errors can be further characterized into 
groups, as demonstrated in Table 1.11
Incidence and prevalence of 
prescribing errors
Prescribing errors occur in all health care settings. In 
hospitalized patients, they are more common in adults than 
in children (median prevalence 18% [interquartile range 
7%–25%] versus median 4% [2%–17%]).12 They occur on 
average 8.8 times per 100 medication orders, and are 70% 
more likely to occur at the time of hospital admission.13 One 
UK study looked at prescribing errors in primary care, and 
found that both patients aged $65 years and under 15 years 
were at highest risk.14 Of these patients, one in eight experi-
enced a prescribing error or monitoring error. Although the 
great majority of these errors were mild to moderate, one in 
550 was deemed clinically serious.14
Care-home residents, the majority of whom have mul-
timorbidity, are at a particularly high risk of prescribing 
errors. A recent large-scale US study reported that 93% of 
nursing-home residents had three or more conditions and on 
average were prescribed eight medications daily.15 Another 
study found that medication errors occurred in two-thirds of 
residents, and prescribing errors, as defined by Dean et al, 
occurred in 39.1%.16 The most common types of prescribing 
errors seen in this cohort were “incomplete information” 
(no route or dose specified) at 37.9%, “unnecessary drug” 
at 23.5%, “dose error” at 14.4%, and “omission errors” at 
11.8%.16 Notably, care-home residents are at the highest risk 
of prescribing errors, as well as administration and dispensing 
error, when they move between primary and secondary care.17 
This is concerning for the future in view of the growing popu-
lations of nursing-home residents in developed countries. For 
instance, 7% of people aged $65 years in Ireland18 and 3% 
of similarly aged people in the US live in nursing homes.19,20 
It is highly probable that prescribing errors will increase in 
this growing population of frail older people unless improved 
reliable systems for detection and correction of medication 
errors are put in place.
Causes of prescribing errors
Developing strategies to reduce prescribing errors in older 
adults is dependent on identifying the key causative factors 
that lead to these errors. One Dutch study found that pre-
scriber and drug characteristics were the factors most strongly 
associated with prescribing errors.21 Several other factors are 
also associated with prescribing errors in older people. Dean 
et al have divided these into categories of individual and team 
factors, patient-related factors, work-environment factors, 
and task-related factors.22 Details of these prescribing-error 
risk factors are illustrated in Figure 1.
Doctors often work in stressful and busy environments, 
with frequent distractions that may impinge on thought 
processes while prescribing. Junior doctors, who do the 
majority of prescribing within hospitals, frequently rotate 
from one specialist department to another, needing to adapt 
quickly to a new cluster of commonly prescribed drugs 
within that specialty. Because of various other demands on 
Table 1 Classification of prescribing errors
Omission error Deletion of a drug previously used
Commission error Addition of a drug not previously used
Dosing error Incorrect dose
Frequency error Incorrect frequency
Form error Incorrect form
Substitution error A drug from one class substituted for another 
drug from the same class not previously used
Duplication error Two drugs from the same class being prescribed
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their attention in their day-to-day work, junior trainees may 
depend on nurses and pharmacists to identify prescribing 
errors, particularly in nonelectronic prescribing systems.
Older persons who become acutely ill may be assessed by 
general practitioners on call or admitted to hospital by doctors 
who do not know their clinical details outside normal working 
hours. Alongside this, access to older persons’ community 
pharmacist records, hospital medical records, and primary 
care records may be suboptimal. Consequently, there is an 
increased risk of prescribing errors occurring, and such errors 
may not be identified and addressed for some considerable 
time after hospital admission, by which time an adverse 
clinical consequence may have occurred.
Prescribing errors may originate with older persons 
themselves when discussing their medications, particularly 
frailer older multimorbid patients who have complex 
daily medications routines when they are acutely unwell. 
Such conditions as dementia, acute stroke, or delirium are 
common in older people, and often impede their capacity 
to communicate clearly. In such circumstances, medication 
reconciliation (MR), the process of compiling a patient’s 
detailed medication list, can be difficult or sometimes 
impossible if the attending hospital physician does not 
have access to the patient’s primary care clinical records. 
Although GPs know which drugs are being prescribed to 
their older multimorbid patients, not uncommonly they are 
unaware of the full list of drugs that older patients actually 
take. Frank et al reported that approximately 40% of older 
patients take drugs that their GP is unaware of and that 5% 
of patients do not take medications listed on their primary 
care prescription record.23 It is not surprising that prescrib-
ing errors happen most frequently at the time of transition 
of care, particularly on admission to hospital, when older 
patients have their medications prescribed by a doctor who 
is usually unknown to them.24
Age-related pharmacokinetics, 
pharmacodynamics, and prescribing 
errors
Everybody who prescribes for older people needs to be aware 
of the important physiological changes that occur with aging 
that affect drug pharmacokinetics (absorption, distribution, 
metabolism, and excretion) and pharmacodynamics (the 
effect a drug has on the body). These changes predispose 
older people to adverse outcomes arising from prescribing 
errors. Figure 2 summarizes the key pharmacokinetic changes 
associated with old age.
Absorption may be affected by drugs that are commonly 
prescribed in older people, such as anticholinergic drugs, 
which reduce the production of saliva, and proton-pump 
inhibitors, which reduce gastric acid secretion. With advanc-
ing age, muscle mass declines, with a resultant proportional 
increase in total body fat. These changes affect the volume 
of distribution of both lipophilic drugs, such as benzodiaz-
epines, and hydrophilic drugs, such as lithium. Consequently, 
in older adults lipophilic drugs have a larger volume of 
distribution, which results in a longer half-life, a tendency 
to drug accumulation, and a lower threshold for adverse 
Figure 1 Classification of factors that predispose to prescribing errors.
• Prescriber knowledge of medications
• Prescriber knowledge of patient comorbidities
• Responsibility for prescribing often placed on the most junior member of teams
• Patient’s knowledge of their medication
• Patient’s honesty regarding their medication use
• Patient’s ability to communicate their medication use
• Patient’s comorbidities
• Prescription type required
• Legibility of prescription
• Clear explanation for pharmacist and patient 
• Sufficient staffing
• Sufficient time allocated for prescribing
• Comfortable workload
• Easy in-hours and out-of-hours access to pharmacist, GP and medical records
Patient-related
factors
Work-environment
factors
Task-related
factors
Individual and team
factors
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drug reactions (ADRs). When the volume of distribution of 
hydrophilic drugs is reduced, the risk of toxicity is greater if 
doses are not adjusted, particularly where there is coexisting 
renal impairment.
Chronic illness and malnutrition can lower serum albumin 
levels, which in turn can affect highly protein-bound drugs, 
such as ibuprofen and phenytoin. This results in an increased 
concentration of circulating free drug and a lower threshold 
for adverse effects. Liver mass and perfusion declines by 
approximately 30%–40% with advancing age,25 impacting 
on drugs with high hepatic extraction ratio, such as warfarin. 
This results in a reduction in first-pass metabolism, an 
increase in bioavailability, and the potential for high serum 
drug levels.
Drug–drug interactions within the cytochrome P450 
enzyme system of the liver are of particular concern in older 
adults on multiple medications. For example, an older per-
son prescribed clarithromycin in tandem with warfarin can 
experience bleeding due to inhibition of warfarin metabolism. 
In other circumstances, the combination of certain drugs 
with similar pharmacological effects can result in signifi-
cant toxicity, eg, haloperidol prescribed with amitriptyline 
increases the potential for major anticholinergic side effects, 
such as severe constipation and even delirium.
Renal size, perfusion, and function decline with aging, 
leading to a reduction in glomerular filtration rate (GFR).26 
This affects the elimination of medications, and doses need 
to be adjusted accordingly. This is particularly relevant 
when older adults become acutely unwell, when their GFR 
may decline significantly, thereby increasing their risk of 
certain ADRs with drugs that are mainly excreted through 
the kidneys, eg, digoxin, lithium, aminoglycosides, and rivar-
oxaban. ADRs in turn often prolong admission,27 resulting 
in higher risk of morbidity and mortality,28 as well as greater 
hospital costs.27 Calculation of estimated GFR is therefore 
recommended for renally eliminated drugs each time a pre-
scription is written. Serum creatinine concentration alone 
as an indicator of renal function may be misleading, since 
approximately 50% of older adults with normal creatinine 
have a reduced estimated GFR.29
Older multimorbid adults are more sensitive to the effects 
of certain commonly prescribed drugs compared to younger 
adults. Pathological changes to organs, differences in receptor 
affinities and densities, and changes in postreceptor events at 
a cellular level may alter pharmacodynamics. As a result of 
pharmacodynamic changes, older people are more sensitive 
to the effects of such drugs as warfarin, opioids, furosemide, 
neuroleptic antipsychotics, and benzodiazepines. For this 
reason, prescribers should initiate these drugs at the lowest 
possible dose and titrate slowly.
As a result of these age-related pharmacokinetic and phar-
macodynamic changes, prescribing errors when they occur 
in older adults are more likely to have clinical consequences. 
Although most medication errors do not lead to ADEs, those 
that do cause ADEs are mostly preventable.30 In one study 
of approximately 36,200 prescriptions, prescribing errors 
Figure 2 Age-related changes in pharmacokinetics.
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were found in 1.5% of cases, with about a quarter of these 
having the potential to cause serious harm to the patient.31 
Most errors in this study related to dosing. There are multiple 
factors that contribute to prescribing errors; therefore, a 
multifaceted strategy is required to minimize them and their 
potentially adverse consequences.
Methods to reduce prescribing 
errors
education
Although many nurses and pharmacists have assumed 
prescribing responsibilities, the majority of prescribing is still 
carried out by doctors. Most medical schools provide some 
training in prescribing to medical undergraduates; however, 
this training is perceived to be suboptimal by medical students 
and junior doctors.32 A UK prospective cross-sectional study 
across three universities reported that medical students were 
underprepared for prescribing, with weaknesses identified 
in clinical pharmacology/therapeutic knowledge and the 
practical elements of drug prescribing, such as calculating 
doses and writing prescriptions correctly.33 Notably, doctors 
in their first 2 years of postgraduate practice are twice 
as likely to prescribe incorrectly compared to medical 
consultants.13
The recent PROTECT study of prescribing performance 
in foundation doctors in Scotland reported that these founda-
tion doctors made more prescribing errors than other doctors; 
perhaps not surprisingly, as they undertake the majority of 
prescribing in hospital.34 Prescribing errors occurred at a 
significantly higher rate in teaching hospitals (P,0.001), 
surgical wards (P#0.001), or mixed medical and surgical 
(P=0.008) wards compared to medical wards. Prescription 
errors were also significantly higher where there was a higher 
patient turnover (P,0.001), a greater number of prescribed 
medicines (P,0.001), and during the months of December 
and June (P,0.001). The study concluded that prescribing 
errors in foundation doctors were multifactorial, involving 
work environment, team, task, individual, and patient factors. 
For this reason, corrective action among junior doctors needs 
to be multifaceted.
In 2009, a systematic review35 of prescribing-optimization 
interventions identified the World Health Organization’s 
Guide to Good Prescribing36 as the only intervention tested 
on students that was shown to have significant improvements 
on prescribing. More recently, a Dutch randomized controlled 
trial involving 106 medical students found that students 
trained in the use of the STRIP (systematic tool to reduce IP) 
software tool alongside the deployment of STOPP/START 
(screening tool of older people’s prescriptions/screening tool 
to alert to right treatment) criteria37 performed significantly 
better on a battery of prescribing-skill assessment tests than 
students who did not receive training in STRIP or STOPP/
START criteria.38 With regard to physicians’ continuing med-
ication education, interactive techniques have been shown to 
change physician practices and improve patient care.39
A recent metasynthesis by Cullinan et al examined the 
core reasons for IP in older people.40 Of 624 qualitative 
research papers in the literature, only seven papers were iden-
tified as relevant. Using metaethnographic methods to synthe-
size these seven papers, the following factors were identified 
as significant contributors to IP: 1) need to satisfy the 
patient, 2) feeling of being forced to prescribe, 3) prescribing 
experience prevailing over prescribing guidelines, and 
4) prescribers’ feelings of fear of countermanding other 
physicians’ prescription orders. A follow-up study of hospital 
doctors,41 again using qualitative methodology, examined 
the core barriers to appropriate prescribing in older people 
and types of interventions likely to improve prescribing 
appropriateness. This study found that the key factors that 
influence prescribing appropriateness were environmental 
context and resources, knowledge, skills, social influences, 
and memory/attention and decision processes. The authors 
concluded that prescribing training and improved prescribing 
environment were most likely to have a positive impact of 
prescribing appropriateness in older people. In a follow-on 
randomized control trial, Cullinan et al examined the impact 
of a structured online geriatric prescribing-education program 
in junior hospital doctors.42 The doctors who received the 
online education performed significantly better in a subse-
quent assessment of their geriatric prescribing knowledge 
than the doctors who did not receive the education. The 
intervention was low-cost, reproducible, and user-friendly, 
as evidenced by the low rate of attrition of doctors in the 
intervention arm of the trial.
Education techniques that have been proven beneficial 
should be implemented for prescribing training at both under-
graduate and postgraduate level. They should be targeted at 
those who make most errors, ie, junior doctors, and should 
focus on locations where errors occur most commonly, 
ie, hospitals.
In view of the global aging demographic shift and the 
fact that older multimorbid patients are more vulnerable to 
prescribing errors, it is imperative that medical students and 
doctors receive appropriate training in geriatric medicine and 
geriatric pharmacotherapy, regardless of the career path they 
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
3.
23
9.
10
2.
11
3 
on
 2
5-
Fe
b-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Interventions in Aging 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
862
Lavan et al
intend to take. To date, most undergraduate curricula have 
been lacking in these important areas, although there have 
been significant concerted efforts recently in Europe43 and 
elsewhere to address this deficiency.
Medication reconciliation
Most prescribing errors occur at the time of admission to 
hospital.24 For this reason, MR is advisable in all older 
people at the point of entry to hospital. The four steps of 
MR are: verification of all drugs, both prescription and 
nonprescription, currently being taken by the patient; 
clarification/evaluation of each drug for appropriateness 
in this particular case; reconciliation of the new complete 
drug list with the previous drug list, with documentation 
of all medication changes and reasons for changes; and 
transmission/communication of the updated accurate drug 
list to the next care provider.
SHiM (structured history taking of medication use) is a 
recently devised and validated tool designed to assist doctors 
and pharmacists to carry out MR in a structured fashion. Its 
use has been shown to highlight medication discrepancies of 
potential clinical relevance in approximately 20% of elderly 
patients.44 Outside the Netherlands (where it originated), 
SHiM has not been used as a routine tool in clinical practice. 
Appropriate software to support its deployment may increase 
its routine use as a means of rapid structured MR.
Pharmacists
Hospital-based clinical pharmacists can identify prescribing 
errors through MR. However, after identification of these 
errors, the next vital step is to advise medical teams on how 
to rectify these errors. When pharmacists’ recommendations 
are adhered to, patient outcomes improve.43,45 Feedback to 
the prescriber about prescribing errors could potentially 
reduce the risk of repeated errors, particularly when pre-
scriber knowledge has been shown to be one of the two main 
characteristics associated with prescriber errors.21
The input of clinical pharmacists has also been shown 
to reduce prescribing errors in acute hospitals,46 at time of 
discharge,47 and in intensive care settings.48 The number 
of older patients being admitted to intensive care units has 
increased, and will likely continue to increase in tandem with 
global population aging.49 It is important that in addressing 
the problem of prescribing errors, the interventions that 
show improvement are implemented in the places where 
older multimorbid adults attend most frequently and have 
their prescriptions altered. Similar to physicians, clinical 
pharmacists should have structured training in geriatric 
medicine and geriatric pharmacotherapy as undergraduates 
and as postgraduates.
work environment
Doctors’ work environment has been suggested as a cause 
of prescribing errors. Insufficient staffing, large workloads, 
reduced supervision, poor communication, and poor health of 
workers have all been implicated as contributing factors.22
Work environments can be adapted to minimize prescrib-
ing errors. Simple changes like minimizing extraneous noise 
and other distractions in the prescribing environment can 
reduce prescribing errors. Encouraging all prescribers, regard-
less of seniority, to check all prescriptions for correct dose, 
correct formulation, correct mode of delivery, drug–drug and 
drug–disease interactions, and treatment duration is important 
in achieving a culture of careful prescribing. Easy access to 
high-quality formularies (eg, British National Formulary), 
as well as local, national, and international prescribing 
guidelines, in particular conditions in paper and online ver-
sions, also underpins a cautious prescribing culture. As in all 
work environments, senior role models are important. Junior 
prescribers who witness their senior colleagues exercising 
caution and stringency when prescribing for older people, 
particularly those with multimorbid illness and associated 
polypharmacy, are likely to retain good prescribing habits. 
Sufficient staffing levels with appropriate senior supervision 
is another key component to the optimal prescribing culture. 
Prescribing errors, when they occur (particularly those with 
significant clinical consequences for the older patient), should 
be reported and discussed with doctors as a group, so that 
learning opportunities are not missed. Simple changes like the 
introduction of standardized medication prescription charts 
have been shown to reduce the frequency of prescribing 
errors, as well as improve the documentation of ADRs.50
The role of information and 
communication technology
The impact of computer prescriber order entry (CPOE) 
system on prescribing errors has been studied extensively 
in the last 15 years. A recent systematic review concluded 
that the available evidence is not convincing enough to 
recommend CPOE systems as a reliable means of reducing 
prescribing errors.48 The weakness of the evidence in support 
of CPOE and prescribing errors relates to small study-sample 
sizes and suboptimal study design.51 Larger studies are 
needed to investigate the role of CPOE more thoroughly.
Recent studies have indicated that electronic prescribing 
(EP) may decrease ambulatory prescribing errors.52,53 In the 
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hospital setting, EP has been shown to reduce the amount of 
intervention required by pharmacists, and also to reduce sig-
nificantly the rate of prescribing errors (from 3.8% to 2%).54 
These studies relate to prescribing in general rather than 
prescribing in older people in particular, although there is 
no reason to believe that EP would not be beneficial in older 
multimorbid patients with complex polypharmacy.
Prescribing-assessment tools
There are several elderly-specific prescribing quality-
assessment tools in the literature. For the most part, these 
are broadly divided into implicit and explicit prescribing 
criteria. The best-known implicit prescribing criteria set is 
the Medication Appropriateness Index (MAI), first published 
in 1992.55 Hanlon et al, who devised the MAI, proposed 
that it could be used to assist in recognizing prescribing 
errors and improving overall prescribing quality in older 
people.55,56 The MAI addresses ten aspects of each drug 
prescription, as shown in Table 2, aimed at identifying a 
variety of potential prescribing errors. Several research 
studies over the last 20 years have shown that the MAI 
frequently detects potential prescribing errors and predicts 
adverse health outcomes.57 However, as with the SHiM tool, 
MAI is time-consuming, such that its use has for the most 
part remained in the realm of research rather than routine 
clinical practice.
There are several sets of explicit criteria for potential IP 
in older people in the literature. The Beers criteria were the 
first explicit criteria, published in 1991,58 and the fifth itera-
tion of the Beers criteria has been recently published with the 
endorsement of the American Geriatrics Society.59 Explicit 
criteria sets have been reviewed in detail by O’Connor et al60 
with consideration of set strengths and limitations.
In recent years, the STOPP/START criteria have emerged 
as an alternative to the Beers criteria. STOPP/START crite-
ria originated in Ireland, and were first published in 2008.36 
STOPP criteria are designed to detect and highlight common 
and preventable potentially inappropriate medications, while 
the complementary START criteria are focused on potential 
prescribing omissions, ie, common instances of potentially 
inappropriate nonprescription of drugs that are potentially 
highly beneficial to the older person that occur as a result 
of irrational or ageist reasons. The second iteration of the 
STOPP/START criteria was published recently,61 the total 
number of criteria increasing from 87 to 114 between version 
1 and version 2. The STOPP/START criteria arose out of per-
ceived deficiencies of the Beers criteria,62 and were designed 
for deployment in routine clinical practice. In the last 5 years, 
a series of clinical trials has shown tangible clinical benefit 
when STOPP/START criteria are applied to the medication 
lists of older people. Gallagher et al showed that STOPP/
START criteria applied at a single time point within 48 hours 
of acute hospital admission of older people significantly 
improve patients’ medication appropriateness compared to 
standard pharmaceutical care, an effect that was maintained 
to the end of a 6-month post-discharge interval.63 A subse-
quent clinical trial by Frankenthal et al64 showed that routine 
application of the STOPP/START criteria in older nursing-
home residents significantly reduced the average number of 
daily medications, monthly drug cost, and incidence of falls 
compared to standard pharmaceutical care. Another recent 
single-center clinical trial by Dalleur et al65 examined the 
effect of routine application of the STOPP/START criteria 
in elderly acutely ill hospitalized patients seen on consulta-
tion by the specialist multidisciplinary geriatric medical 
team. This trial showed that the proportion of patients taking 
potentially inappropriate drugs at discharge was reduced 
to approximately half that of the control patients receiving 
standard pharmaceutical care (19.3% versus 39.7%).
In essence, the value of any set of prescribing-appropriateness 
criteria can be measured by the relevance of the clinical 
impact that results from routine application of these criteria 
as an intervention in the target elderly population. At pres-
ent, STOPP/START are the only set of explicit geriatric 
prescribing criteria that have shown tangible clinical benefit 
in older people when tested by clinical trials. However these 
clinical trials are limited by their smaller scale, as well as 
their single-center and single-blind designs.
Other prescribing assessment and optimization interven-
tions have been evaluated by RCT, including:
•	 comprehensive geriatric assessment and management 
that significantly reduces serious ADRs66
•	 comprehensive pharmacist intervention that significantly 
attenuates drug-related hospital readmissions67
Table 2 Medication Appropriateness Index
1 Is there an indication for the drug?
2 Is the medication effective for the condition?
3 Is the dosage correct?
4 Are the directions correct?
5 Are the directions practical?
6 Are there clinically significant drug–drug interactions?
7 Are there clinically significant drug–disease interactions?
8 Is there unnecessary duplication with other drugs?
9 Is the duration of therapy acceptable?
10 Is this drug the least expensive alternative compared to others of 
equal utility?
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•	 a staff-education program that results in significantly 
fewer ADEs in geriatric rehabilitation units68
•	 a medication-optimization software system, ie, the Lund 
Integrated Medicines Management model, which brings 
about significant reductions in drug-related emergency 
department attendances and readmissions.69
To date, however, none of these prescribing-optimization 
interventions designed to minimize prescribing errors has 
come into routine clinical use.
Summary
The older multimorbid population is expanding globally, and this 
inevitably means a growth in complex polypharmacy and asso-
ciated problems of IP and ADRs. Prescribing errors are common 
in older people with multimorbid illness and polypharmacy, 
leading to ADRs and events that in turn cause higher levels of 
morbidity, rehospitalization, and mortality. Screening for and 
detection of prescribing errors is a growing challenge facing 
physicians and pharmacists who deal with older multimorbid 
people who experience polypharmacy. CPOE systems have 
not been shown conclusively to lessen prescribing errors and 
associated drug-related morbidity. Making prescribers and 
pharmacists more “age-attuned” in their prescribing practices 
is important, and various prescribing-education models exist 
that can improve prescribing performance.
Medication appropriateness in older people can be mea-
sured and assessed using the MAI and the Assessment of 
Underutilization of Medication tools. However, these are 
time-consuming, and have not, for the most part, moved 
beyond the research domain. Potentially inappropriate 
prescribing, as highlighted by IP criteria sets, such as the 
Beers criteria and STOPP/START criteria, is a common 
problem in older people in primary care, in hospital, and in 
the nursing-home environment. Application of the STOPP/
START criteria to medication lists of older people improves 
medication appropriateness in hospitalized older patients 
and reduces polypharmacy, drug costs, and falls incidence 
in elderly nursing-home residents.
In the future, higher-quality and more efficient computer 
systems will have a greater role in the routine practice of 
optimizing pharmacotherapy of older people, particularly those 
with multimorbid chronic illness and polypharmacy. At pres-
ent, there are two European Union (EU)-funded  multicenter 
trials in preparation (SENATOR and OPERAM), which will 
test two similar software systems in their ability to attenuate 
ADRs and health care costs (SENATOR; EU grant 305930) 
and rehospitalization and composite health care utilization 
(OPERAM; EU grant 634238-2) in older multimorbid people 
recruited from several European clinical sites. The aim of 
these trials is to build, validate, and test by clinical trial soft-
ware systems primarily designed around the STOPP/START 
criteria in the older multimorbid/polypharmacy population, 
with a view to providing commercially available software 
for routine clinical use if these trials demonstrate significant 
and substantial benefit. Even if they do show benefit, their 
implementation into routine prescribing in older people will 
require substantial investment in appropriately trained clinical 
pharmacists and information and communication-technology 
support. Nevertheless, the trend toward EP and medication 
surveillance will facilitate the application of prescription-
optimization software in routine practice.
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